Second, our cross-sectional study limited us to exploring the causal association of FGF23 and α-klotho with T2DM or atherosclerosis in T2DM patients; therefore, prospective studies are needed to validate the practical relevance of these findings. This evidence concerns the gene KL and atherosclerosis.